James E Besser - Net Worth and Insider Trading

James E Besser Net Worth

The estimated net worth of James E Besser is at least $125,412 dollars as of 2024-03-29. James E Besser is the See Remarks of Processa Pharmaceuticals Inc and owns about 52,665 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $125,343. James E Besser is also the 10% Owner of Medifirst Solutions Inc and owns about 696,612 shares of Medifirst Solutions Inc (MFST) stock worth over $70. Details can be seen in James E Besser's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James E Besser has not made any transactions after 2021-04-08 and currently still holds the listed stock(s).

Transaction Summary of James E Besser

To

James E Besser Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James E Besser owns 9 companies in total, including Processa Pharmaceuticals Inc () , Minim Inc () , and SideChannel Inc () among others .

Click here to see the complete history of James E Besser’s form 4 insider trades.

Insider Ownership Summary of James E Besser

Ticker Comapny Transaction Date Type of Owner
Processa Pharmaceuticals Inc 2021-04-08 10 percent owner
Minim Inc 2015-09-25 10 percent owner
SideChannel Inc 2018-07-24 10 percent owner
Medifirst Solutions Inc 2019-05-01 10 percent owner
Modular Medical Inc 2018-11-20 10 percent owner
Fennec Pharmaceuticals Inc 2013-11-22 10 percent owner
NeuroOne Medical Technologies Corp 2021-01-15 10 percent owner
Brain Scientific Inc 2022-06-15 10 percent owner
SANUWAVE Health Inc 2022-06-06 director & other: Director by Deputization

James E Besser Latest Holdings Summary

James E Besser currently owns a total of 2 stocks. Among these stocks, James E Besser owns 52,665 shares of Processa Pharmaceuticals Inc (PCSA) as of April 8, 2021, with a value of $125,343 and a weighting of 99.94%. James E Besser also owns 696,612 shares of Medifirst Solutions Inc (MFST) as of May 1, 2019, with a value of $70 and a weighting of 0.06%.

Latest Holdings of James E Besser

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCSA Processa Pharmaceuticals Inc 2021-04-08 52,665 2.38 125,343
MFST Medifirst Solutions Inc 2019-05-01 696,612 0.00 70

Holding Weightings of James E Besser


James E Besser Form 4 Trading Tracker

According to the SEC Form 4 filings, James E Besser has made a total of 4 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Processa Pharmaceuticals Inc is the sale of 22,389 shares on April 8, 2021, which brought James E Besser around $5 Million.

According to the SEC Form 4 filings, James E Besser has made a total of 1 transactions in Medifirst Solutions Inc (MFST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Medifirst Solutions Inc is the acquisition of 96,612 shares on May 1, 2019, which cost James E Besser around $6,763.

Insider Trading History of James E Besser

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James E Besser Trading Performance

GuruFocus tracks the stock performance after each of James E Besser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E Besser is 8.48%. GuruFocus also compares James E Besser's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E Besser within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James E Besser's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James E Besser

Average Relative Return

6.74%

Average relative return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -22.34 8.48 44.86 6.74 -55.6 -74.68
Relative Return to S&P 500(%) -18.84 1.88 32.39 -6.74 -67.14 -85.09

James E Besser Ownership Network

Ownership Network List of James E Besser

No Data

Ownership Network Relation of James E Besser


James E Besser Owned Company Details

What does Processa Pharmaceuticals Inc do?

Who are the key executives at Processa Pharmaceuticals Inc?

James E Besser is the 10 percent owner of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include director & 10 percent owner & President & CEO David Young , Chief Business - Strategy Off Patrick Lin , and Chief Executive Officer George K Ng .

Processa Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, James E Besser made no insider transaction in Processa Pharmaceuticals Inc (). Other recent insider transactions involving Processa Pharmaceuticals Inc () include a net purchase of 161,000 shares made by David Young , a net purchase of 10,000 shares made by George K Ng , and a net purchase of 8,000 shares made by Justin W Yorke .

In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc () in total and bought 63,000 shares, with a net purchase of 63,000 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc () were sold and 69,000 shares were bought by its insiders, resulting in a net purchase of 69,000 shares.

Processa Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Processa Pharmaceuticals Inc Insider Transactions

No Available Data

James E Besser Mailing Address

Above is the net worth, insider trading, and ownership report for James E Besser. You might contact James E Besser via mailing address: 3 West Hill Place, Boston Ma 02114.

Discussions on James E Besser

No discussions yet.